Search

everythinglearnresearchcommunity

for

Search:↓

Hair aging is inevitable, but using the right hair care products can help maintain hair health.

Use of cosmeceuticals during pregnancy and breastfeeding is not recommended due to insufficient safety data.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Better hair loss models needed for research.

Microneedles improve drug delivery in various body parts, are safe and painless, and show promise in cosmetology, vaccination, insulin delivery, and other medical applications.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Exosome treatment for hair growth is promising but not FDA-approved and needs more research on safety and how it works.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

A blood pressure drug, diltiazem, may also help treat influenza.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

The document concludes that PK/PD modeling is important for determining the safe and effective dosages of drugs.

New treatments for male hair loss show promise but need more research for safety and effectiveness.

The conclusion is that off-label drug use can lead to important medical discoveries and improve patient care.

Different stem cells are key for hair growth and health, and understanding their regulation could help treat hair loss.

Differences in growth factors in platelet-rich plasma therapy for hair loss can vary between patients and can be influenced by the devices used, possibly leading to inconsistent results.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Some plant-based ingredients may help with hair growth and care, but more research is needed to confirm their effectiveness.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Skin and hair can help us understand organ regeneration, especially how certain stem cells might be used to form new organs.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Acankoreoside J from Acanthopanax koreanum may help promote hair growth.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Gold thread implantation may help hair grow in humans and mice.

New treatments targeting T-cell pathways are needed for better alopecia areata management.